IW-1973
C1973-204
Phase 2 small_molecule completed
Quick answer
IW-1973 for Heart Failure With Preserved Ejection Fraction is a Phase 2 program (small_molecule) at Akebia Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Akebia Therapeutics
- Indication
- Heart Failure With Preserved Ejection Fraction
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed